Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Tint

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
American Journal of Medical Genetics|September 15, 1993
Cholesterol defect in Smith-Lemli-Opitz syndromeG S Tint
Journal of Lipid Research|May 1, 1982
Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosisG S Tint, G Salen
The New England Journal of Medicine|March 9, 1989
Nonsurgical treatment of gallstonesG Salen, G S Tint
Metabolism: Clinical and Experimental|July 1, 1977
Evidence for the early reduction of the 24,25 double bond in the conversion of lanosterol to cholesterol in cerebrotendinous xanthomatosisG S Tint, G Salen
Journal of Lipid Research|May 1, 1974
Transformation of 5 alpha-cholest-7-en-3 beta-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosisG S Tint, G Salen
Prenatal Diagnosis|May 29, 1998
Prenatal diagnosis of Smith-Lemli-Opitz syndromeM B Irons, G S Tint
Gastroenterology Clinics of North America|March 1, 1991
Treatment of cholesterol gallstones with litholytic bile acidsG Salen, G S Tint, S Shefer
Steroids|November 1, 1979
C26-analogs of naturally occurring bile alcohols-II. Preparation of 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,23-tetrols (23R and 23S) and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,26-tetrols (25R and 25S) by a hydroboration procedureB Dayal, G S Tint, G Salen
Seminars in Liver Disease|August 1, 1990
Oral dissolution treatment of gallstones with bile acidsG Salen, G S Tint, S Shefer
Gastroenterology|October 1, 1986
Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolismG S Tint, G Salen, S Shefer
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
American Journal of Medical Genetics|September 15, 1993
Cholesterol defect in Smith-Lemli-Opitz syndromeG S Tint
Journal of Lipid Research|May 1, 1982
Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosisG S Tint, G Salen
The New England Journal of Medicine|March 9, 1989
Nonsurgical treatment of gallstonesG Salen, G S Tint
Metabolism: Clinical and Experimental|July 1, 1977
Evidence for the early reduction of the 24,25 double bond in the conversion of lanosterol to cholesterol in cerebrotendinous xanthomatosisG S Tint, G Salen
Journal of Lipid Research|May 1, 1974
Transformation of 5 alpha-cholest-7-en-3 beta-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosisG S Tint, G Salen
Prenatal Diagnosis|May 29, 1998
Prenatal diagnosis of Smith-Lemli-Opitz syndromeM B Irons, G S Tint
Gastroenterology Clinics of North America|March 1, 1991
Treatment of cholesterol gallstones with litholytic bile acidsG Salen, G S Tint, S Shefer
Steroids|November 1, 1979
C26-analogs of naturally occurring bile alcohols-II. Preparation of 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,23-tetrols (23R and 23S) and 24-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,26-tetrols (25R and 25S) by a hydroboration procedureB Dayal, G S Tint, G Salen
Seminars in Liver Disease|August 1, 1990
Oral dissolution treatment of gallstones with bile acidsG Salen, G S Tint, S Shefer
Gastroenterology|October 1, 1986
Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolismG S Tint, G Salen, S Shefer
Pageof 19